Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane

被引:27
作者
Hammarstedt, M [1 ]
Garoff, H [1 ]
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
关键词
D O I
10.1128/JVI.78.11.5686-5697.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 particles form by budding at the surface of most cell types. In this process, a piece of the plasma membrane is modified into an enveloped virus particle. The process is driven by the internal viral protein Pr551(gag). We have studied how host proteins in the membrane are dealt with by Pr55(gag) during budding. Are they included in or excluded from the particle? The question was approached by measuring the relative concentrations of host and viral proteins in the envelope of Pr55(gag) particles and in their donor membranes in the cell. We observed that the bulk of the host proteins, including actin and clathrin, were passively included into the virus-like Gag particles. This result suggests that budding by Pr55(gag) proceeds without significant alteration of the original host protein composition at the cell membrane. Nevertheless, some proteins were concentrated in the particles, and a few were excluded. The concentrated proteins included cyclophilin A and Tsg-101. These were recruited to the plasma membrane by Pr55(gag). The membrane-bound cyclophilin A was concentrated into particles as efficiently as Pr55(gag), whereas Tsg-101 was concentrated more efficiently. The latter finding is consistent with a role for Tsg-101 in Gag particle release.
引用
收藏
页码:5686 / 5697
页数:12
相关论文
共 45 条
[1]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[2]   Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations [J].
Bess, JW ;
Gorelick, RJ ;
Bosche, WJ ;
Henderson, LE ;
Arthur, LO .
VIROLOGY, 1997, 230 (01) :134-144
[3]   Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells [J].
Braaten, D ;
Luban, J .
EMBO JOURNAL, 2001, 20 (06) :1300-1309
[4]   Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3551-3560
[5]  
CHENG RH, 1995, CELL, V80, P621
[6]   Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function [J].
Demirov, DG ;
Ono, A ;
Orenstein, JM ;
Freed, EO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :955-960
[7]   Highly purified human immunodeficiency virus type 1 reveals a virtual absence of vif in virions [J].
Dettenhofer, M ;
Yu, XF .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1460-1467
[8]   Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation [J].
Esser, MT ;
Graham, DR ;
Coren, LV ;
Trubey, CM ;
Bess, JW ;
Arthur, LO ;
Ott, DE ;
Lifson, JD .
JOURNAL OF VIROLOGY, 2001, 75 (13) :6173-6182
[9]   Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors [J].
Follenzi, A ;
Sabatino, G ;
Lombardo, A ;
Boccaccio, C ;
Naldini, L .
HUMAN GENE THERAPY, 2002, 13 (02) :243-260
[10]   Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography [J].
Forster, MJ ;
Mulloy, B ;
Nermut, MV .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (05) :841-857